ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 74 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,096,000 | -0.7% | 625,080 | +5.8% | 1.39% | +20.1% |
| Q2 2021 | $3,119,000 | +20.7% | 590,730 | +9.7% | 1.16% | -7.4% |
| Q1 2021 | $2,584,000 | +165.0% | 538,395 | +139.2% | 1.25% | +62.3% |
| Q4 2020 | $975,000 | +5.2% | 225,106 | 0.0% | 0.77% | +1.6% |
| Q3 2020 | $927,000 | +48.6% | 225,106 | -7.6% | 0.76% | +148.4% |
| Q2 2020 | $624,000 | +37.4% | 243,706 | +55.1% | 0.31% | +9.7% |
| Q1 2020 | $454,000 | +14.6% | 157,142 | +103.1% | 0.28% | +23.5% |
| Q3 2019 | $396,000 | -27.3% | 77,384 | -12.0% | 0.23% | -25.2% |
| Q2 2019 | $545,000 | +28.2% | 87,908 | +47.2% | 0.30% | +27.4% |
| Q1 2019 | $425,000 | – | 59,740 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |